5 Pharmaceutical Stocks to Buy According to Efrem Kamen’s Pura Vida Investments

2. Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Number of Hedge Fund Holders: 18

Efrem Kamen’s Pura Vida Investments has been holding a position in Establishment Labs Holdings Inc. (NASDAQ:ESTA) since the third quarter of 2018. The firm benefitted from its position as shares rallied sharply in the past two years. The global medical technology company posted sales of $29.0 million in the third quarter, an increase of 27.6% year-over-year. It expects full-year sales in the range of $124 million to $128 million, reflecting a 46% to 51% increase from the past year. 

Hedge funds sentiment increased in Establishment Labs Holdings Inc. (NASDAQ:ESTA) during the third quarter. The number of long hedge funds’ positions jumped to 18 as of September. Joseph Edelman’s Perceptive Advisors and Efrem Kamen’s Pura Vida Investments were the leading stakeholders in the company.